View in EDS

Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Saved in:
Bibliographic Details
Title: Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.
Authors: van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands., Iacoboni G; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Hess G; Department of Hematology/Oncology, Johannes Gutenberg-Universität Mainz, Mainz, Germany., Mutsaers P; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., García-Sancho AM; Department of Hematology, Salamanca University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, University of Salamanca, Salamanca, Spain., Goy A; John Theurer Cancer Center, Hackensack, NJ., Giné E; Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain., Hill BT; Cleveland Clinic Foundation, Cleveland, OH., Weng WK; Department of Medicine, Stanford University, Stanford, CA., Reagan PM; Department of Medicine, University of Rochester Medical Center, Rochester, NY., Patel K; Swedish Cancer Institute, Seattle, WA., Galal A; Carol G. Simon Cancer Center, Morristown, NJ., Herbaux C; Department of Clinical Hematology, Hématologie Clinique, Centre Hospitalier Universitaire Montpellier, Montpellier, France., Sanderson R; Department of Haematology, King's College Hospital, London, United Kingdom., Forcade E; Department of Clinical Hematology and Cellular Therapy, Service d'Hématologie Clinique et Thérapie Cellulaire, Bordeaux, France., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Houot R; Department of Hematology, Centre Hospitalier Universitaire Rennes, Université Rennes, INSERM, Établissement Français du Sang, Rennes, France., Zheng D; Kite, a Gilead company, Santa Monica, CA., Zhang W; Kite, a Gilead company, Santa Monica, CA., Kanska J; Kite, a Gilead company, Santa Monica, CA., Shen RR; Kite, a Gilead company, Santa Monica, CA., Damico Khalid R; Kite, a Gilead company, Santa Monica, CA., Kloos I; Kite, a Gilead company, Santa Monica, CA., Dreyling M; Department of Medicine III, Ludwig Maximilian University Hospital of Munich, Munich, Germany., Wang ML; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Source: Blood [Blood] 2026 Mar 19; Vol. 147 (12), pp. 1302-1314.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41160777
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Meerten+T%22">van Meerten T</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Iacoboni+G%22">Iacoboni G</searchLink>; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hess+G%22">Hess G</searchLink>; Department of Hematology/Oncology, Johannes Gutenberg-Universität Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Mutsaers+P%22">Mutsaers P</searchLink>; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22García-Sancho+AM%22">García-Sancho AM</searchLink>; Department of Hematology, Salamanca University Hospital of Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, University of Salamanca, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Goy+A%22">Goy A</searchLink>; John Theurer Cancer Center, Hackensack, NJ.<br /><searchLink fieldCode="AU" term="%22Giné+E%22">Giné E</searchLink>; Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Cáncer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Cleveland Clinic Foundation, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Weng+WK%22">Weng WK</searchLink>; Department of Medicine, Stanford University, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Reagan+PM%22">Reagan PM</searchLink>; Department of Medicine, University of Rochester Medical Center, Rochester, NY.<br /><searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; Swedish Cancer Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Galal+A%22">Galal A</searchLink>; Carol G. Simon Cancer Center, Morristown, NJ.<br /><searchLink fieldCode="AU" term="%22Herbaux+C%22">Herbaux C</searchLink>; Department of Clinical Hematology, Hématologie Clinique, Centre Hospitalier Universitaire Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Sanderson+R%22">Sanderson R</searchLink>; Department of Haematology, King's College Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Forcade+E%22">Forcade E</searchLink>; Department of Clinical Hematology and Cellular Therapy, Service d'Hématologie Clinique et Thérapie Cellulaire, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Topp+MS%22">Topp MS</searchLink>; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; Department of Hematology, Centre Hospitalier Universitaire Rennes, Université Rennes, INSERM, Établissement Français du Sang, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Zheng+D%22">Zheng D</searchLink>; Kite, a Gilead company, Santa Monica, CA.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Kite, a Gilead company, Santa Monica, CA.<br /><searchLink fieldCode="AU" term="%22Kanska+J%22">Kanska J</searchLink>; Kite, a Gilead company, Santa Monica, CA.<br /><searchLink fieldCode="AU" term="%22Shen+RR%22">Shen RR</searchLink>; Kite, a Gilead company, Santa Monica, CA.<br /><searchLink fieldCode="AU" term="%22Damico+Khalid+R%22">Damico Khalid R</searchLink>; Kite, a Gilead company, Santa Monica, CA.<br /><searchLink fieldCode="AU" term="%22Kloos+I%22">Kloos I</searchLink>; Kite, a Gilead company, Santa Monica, CA.<br /><searchLink fieldCode="AU" term="%22Dreyling+M%22">Dreyling M</searchLink>; Department of Medicine III, Ludwig Maximilian University Hospital of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Wang+ML%22">Wang ML</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 Mar 19; Vol. 147 (12), pp. 1302-1314.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41160777
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2025029734
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1302
    Titles:
      – TitleFull: Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Meerten T
      – PersonEntity:
          Name:
            NameFull: Kersten MJ
      – PersonEntity:
          Name:
            NameFull: Iacoboni G
      – PersonEntity:
          Name:
            NameFull: Hess G
      – PersonEntity:
          Name:
            NameFull: Mutsaers P
      – PersonEntity:
          Name:
            NameFull: García-Sancho AM
      – PersonEntity:
          Name:
            NameFull: Goy A
      – PersonEntity:
          Name:
            NameFull: Giné E
      – PersonEntity:
          Name:
            NameFull: Hill BT
      – PersonEntity:
          Name:
            NameFull: Weng WK
      – PersonEntity:
          Name:
            NameFull: Reagan PM
      – PersonEntity:
          Name:
            NameFull: Patel K
      – PersonEntity:
          Name:
            NameFull: Galal A
      – PersonEntity:
          Name:
            NameFull: Herbaux C
      – PersonEntity:
          Name:
            NameFull: Sanderson R
      – PersonEntity:
          Name:
            NameFull: Forcade E
      – PersonEntity:
          Name:
            NameFull: Topp MS
      – PersonEntity:
          Name:
            NameFull: Houot R
      – PersonEntity:
          Name:
            NameFull: Zheng D
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Kanska J
      – PersonEntity:
          Name:
            NameFull: Shen RR
      – PersonEntity:
          Name:
            NameFull: Damico Khalid R
      – PersonEntity:
          Name:
            NameFull: Kloos I
      – PersonEntity:
          Name:
            NameFull: Dreyling M
      – PersonEntity:
          Name:
            NameFull: Wang ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 03
              Text: 2026 Mar 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 147
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1